Glenn Goddard - Net Worth and Insider Trading
Glenn Goddard Net Worth
The estimated net worth of Glenn Goddard is at least $675,740 dollars as of 2024-11-13. Glenn Goddard is the EVP, CFO of Intellia Therapeutics Inc and owns about 40,585 shares of Intellia Therapeutics Inc (NTLA) stock worth over $675,740. Glenn Goddard is also the Senior Vice President, Finance of Agios Pharmaceuticals Inc and owns about 0 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $0. Details can be seen in Glenn Goddard's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Glenn Goddard has not made any transactions after 2024-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Glenn Goddard
Glenn Goddard Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Glenn Goddard owns 2 companies in total, including Intellia Therapeutics Inc (NTLA) , and Agios Pharmaceuticals Inc (AGIO) .
Click here to see the complete history of Glenn Goddard’s form 4 insider trades.
Insider Ownership Summary of Glenn Goddard
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-03 | See Remarks |
| AGIO | Agios Pharmaceuticals Inc | 2015-09-24 | Vice President & Finance |
Glenn Goddard Latest Holdings Summary
Glenn Goddard currently owns a total of 2 stocks. Among these stocks, Glenn Goddard owns 40,585 shares of Intellia Therapeutics Inc (NTLA) as of January 3, 2024, with a value of $675,740 and a weighting of 100%. Glenn Goddard also owns 0 shares of Agios Pharmaceuticals Inc (AGIO) as of September 24, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of Glenn Goddard
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-03 | 40,585 | 16.65 | 675,740 |
| AGIO | Agios Pharmaceuticals Inc | 2015-09-24 | 0 | 59.02 | 0 |
Holding Weightings of Glenn Goddard
Glenn Goddard Form 4 Trading Tracker
According to the SEC Form 4 filings, Glenn Goddard has made a total of 6 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 5,365 shares on January 3, 2024, which brought Glenn Goddard around $158,053.
According to the SEC Form 4 filings, Glenn Goddard has made a total of 0 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 6,000 shares on September 24, 2015, which brought Glenn Goddard around $515,820.
Insider Trading History of Glenn Goddard
- 1
Glenn Goddard Trading Performance
Glenn Goddard Ownership Network
Ownership Network List of Glenn Goddard
Ownership Network Relation of Glenn Goddard
Glenn Goddard Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Glenn Goddard is the See Remarks of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Glenn Goddard made 1 insider transaction in Intellia Therapeutics Inc (NTLA) with a net sale of 5,365. Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 10,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .
In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 62,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,207 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
Glenn Goddard Mailing Address
Above is the net worth, insider trading, and ownership report for Glenn Goddard. You might contact Glenn Goddard via mailing address: C/o Intellia Therapeutics, Inc, 40 Erie Street, Suite 130, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
